T56.7X2
Toxic effect of beryllium and its compounds, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
The code T56.7X2 refers to a clinical condition involving the toxic effect of beryllium and its compounds, caused by intentional self-harm. This condition highlights the health risks associated with exposure to beryllium, a lightweight metal used in various industries, when it is deliberately introduced into the body. Recognizing the causes, symptoms, and treatment options related to beryllium poisoning is essential for healthcare providers and others involved in managing such cases.
Causes & Symptoms
Clinical Causes: Intentional ingestion or inhalation of beryllium or its compounds Deliberate exposure in occupational or environmental settings Use of beryllium in certain industrial or laboratory environments without proper safety measures Self-harm behaviors involving access to beryllium-containing materials
Key Symptoms: Respiratory issues like cough, shortness of breath, and chest pain General fatigue and weakness Skin rashes or irritation upon contact Fever and flu-like symptoms Lymphadenopathy (swollen lymph nodes) Potential signs of systemic toxicity, including nausea and abdominal discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical assessment and laboratory testing. Healthcare professionals may perform the following:
Treatment Protocols: Treatment strategies aim to remove or reduce beryllium exposure, manage symptoms, and support recovery. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is T56.7X2 a billable ICD-10 code?
Yes, T56.7X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T56.7X2?
Clinical documentation must specify the nature of Toxic effect of beryllium and its compounds, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference